Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart Failure Highlights: Late-breaking research | Predicting post-TAVR hospitalizations | HFpEF & MR
Friday, October 7, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Failure

Links to the American Heart Association 2022 late-breaking studies

The American Heart Association 2022 Scientific Sessions included 35 late-breaking studies and 39 featured science sessions presented at the meeting in Chicago, Nov. 5-7. Here is the list of all these studies with links to more information on the data.

READ MORE >
Image from the American Heart Association (AHA) annual scientific sessions where a large amount of late-breaking cardiology science is presented. #AHA #AHA22 #AHA2022
Share on Twitter Share on Facebook Share on Linkedin

Links to the American Heart Association 2022 late-breaking studies

Share on Twitter Share on Facebook Share on Linkedin
Image from the American Heart Association (AHA) annual scientific sessions where a large amount of late-breaking cardiology science is presented. #AHA #AHA22 #AHA2022
The American Heart Association 2022 Scientific Sessions included 35 late-breaking studies and 39 featured science sessions presented at the meeting in Chicago, Nov. 5-7. Here is the list of all these studies with links to more information on the data.
READ MORE >

5 key predictors of heart failure hospitalizations after TAVR

Diabetes and atrial fibrillation are just some of the factors that can increase a patient's risk of being hospitalized for heart failure within one year of undergoing a successful TAVR procedure.

READ MORE >
hospital ward
Share on Twitter Share on Facebook Share on Linkedin

5 key predictors of heart failure hospitalizations after TAVR

Share on Twitter Share on Facebook Share on Linkedin
hospital ward
Diabetes and atrial fibrillation are just some of the factors that can increase a patient's risk of being hospitalized for heart failure within one year of undergoing a successful TAVR procedure.
READ MORE >

Can strength and endurance training help heart failure patients live longer?

Researchers have received a five-year grant worth $30 million to study how a new-look physical rehab program impacts outcomes among older HFpEF patients.

READ MORE >
Wake Forest University School of Medicine has received a five-year grant worth $30 million from the National Institute of Aging, part of the National Institutes of Health, to study the potential benefits of a new-look rehabilitation program on patients who are hospitalized with heart failure with preserved ejection fraction (HFpEF).
Share on Twitter Share on Facebook Share on Linkedin

Can strength and endurance training help heart failure patients live longer?

Share on Twitter Share on Facebook Share on Linkedin
Wake Forest University School of Medicine has received a five-year grant worth $30 million from the National Institute of Aging, part of the National Institutes of Health, to study the potential benefits of a new-look rehabilitation program on patients who are hospitalized with heart failure with preserved ejection fraction (HFpEF).
Researchers have received a five-year grant worth $30 million to study how a new-look physical rehab program impacts outcomes among older HFpEF patients.
READ MORE >

Impella heart pumps boost survival up to 81% for cardiogenic shock patients

The heart pumps appear to provide significant benefits for patients with acute myocardial infarction- or myocarditis-related cardiogenic shock. 

READ MORE >
High-risk percutaneous coronary intervention (PCI) with an Impella heart pump is associated with better outcomes, including a significantly higher survival rate, than high-risk PCI with an intra-aortic balloon pump (IABP), according to new findings published in the American Journal of Cardiology. Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock
Share on Twitter Share on Facebook Share on Linkedin

Impella heart pumps boost survival up to 81% for cardiogenic shock patients

Share on Twitter Share on Facebook Share on Linkedin
High-risk percutaneous coronary intervention (PCI) with an Impella heart pump is associated with better outcomes, including a significantly higher survival rate, than high-risk PCI with an intra-aortic balloon pump (IABP), according to new findings published in the American Journal of Cardiology. Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock
The heart pumps appear to provide significant benefits for patients with acute myocardial infarction- or myocarditis-related cardiogenic shock. 
READ MORE >

HFpEF patients with MR may face a higher mortality risk—but not if they have AFib

There is an established connection between MR and HFrEF, but we know much less about the link between MR and HFpEF. 

READ MORE >
USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.
Share on Twitter Share on Facebook Share on Linkedin

HFpEF patients with MR may face a higher mortality risk—but not if they have AFib

Share on Twitter Share on Facebook Share on Linkedin
USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.
There is an established connection between MR and HFrEF, but we know much less about the link between MR and HFpEF. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme